trial

EEG Outcomes From Cognitive Behavioural Therapy for Psychosis

NCTId NCT05703698
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 20 (actual)
Sponsored by University of Toronto
Primary completion 2024-11-13
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
20 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2023-02-01
Primary completion
2024-11-13
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Cognitive Behavioural Therapy for Psychosis

Sponsors

University of TorontoLead Sponsor
Ontario Shores Centre for Mental Health SciencesCollaborator

Investigators

1
Michael C Davis, M.D., Ph.D.Principal Investigator

Sites

1 total
Scarborough Village, Canada

Facts & assertions

4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2024-11-13
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Behavioural Therapy for Psychosis
drug
lead_sponsor
University of Toronto
company
collaborator
Ontario Shores Centre for Mental Health Sciences
company
indication
Schizophrenia and Related Disorders
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Michael C Davis, M.D., Ph.D.
person